2/3
02:19 am
adxn
Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment [Yahoo! Finance]
Low
Report
Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment [Yahoo! Finance]
2/3
01:00 am
adxn
Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment
Low
Report
Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment
1/7
01:37 am
adxn
Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia [Yahoo! Finance]
Low
Report
Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia [Yahoo! Finance]
1/7
01:00 am
adxn
Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia
Low
Report
Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia
12/11
01:00 am
adxn
Addex Amends its at the Market Offering Agreement With H.C. Wainwright & Co.
High
Report
Addex Amends its at the Market Offering Agreement With H.C. Wainwright & Co.
12/4
07:03 pm
adxn
Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call Highlights: Strategic Advances Amidst ... [Yahoo! Finance]
Medium
Report
Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call Highlights: Strategic Advances Amidst ... [Yahoo! Finance]
12/4
01:00 am
adxn
Addex Therapeutics Reports 2025 Third Quarter Financial Results and Provides Corporate Update
Low
Report
Addex Therapeutics Reports 2025 Third Quarter Financial Results and Provides Corporate Update